Skip to content

Clinical Study Evaluating an Acetabular Cup System After Total Hip Replacement

Multi-center, Prospective, Clinical Evaluation of Pinnacle Acetabular Implants in Total Hip Arthroplasty

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00306930
Enrollment
1593
Registered
2006-03-27
Start date
2000-07-31
Completion date
2012-12-31
Last updated
2014-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Fracture, Arthritis, Avascular Necrosis, Osteoarthritis, Rheumatoid Arthritis

Keywords

Total Hip Replacement, post-traumatic arthritis

Brief summary

This study is a clinical evaluation of survivorship of an acetabular cup system after total hip replacement using patient examinations and questionnaires.

Detailed description

The primary objective of this investigation is to evaluate survivorship at five years of the Pinnacle™ acetabular cup system in primary total hip arthroplasty.

Interventions

Acetabular cup replacement

Sponsors

DePuy Orthopaedics
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Primary hip replacement * Sufficient bone stock to support implant * Signed Informed Patient Consent form

Exclusion criteria

* Prior renal transplant * History of active joint sepsis * Recent high dose of corticosteroids * Primary or secondary carcinoma in the last 5 years * Neurological disease * Psychosocial disease that would limit rehabilitation * Use of structural bone graft * Simultaneous participation in another hip study

Design outcomes

Primary

MeasureTime frame
Survivorship5 years

Secondary

MeasureTime frame
Harris Hip ScorePre-operative, 6 month and 1, 2, 3, 4, and 5 years.
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)Pre-operative, 6 month and 1, 2, 3, 4 and 5 years.
Short Form-36 (SF-36)Pre-operative, 6 month and 1, 2, 3, 4 and 5 years.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026